Paper41349548
Harnessing the Microbiome in Cancer Immunotherapy: Regulation, Prediction, and Therapeutic Targeting.
Zarour HM and 1 other. Annu Rev Immunol, 2026. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Harnessing the Microbiome in Cancer Immunotherapy: Regulation, Prediction, and Therapeutic Targeting. Papers, record 41349548. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41349548
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Harnessing the Microbiome in Cancer Immunotherapy: Regulation, Prediction, and Therapeutic Targeting.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Immunotherapy | Major topic |
| Microbiota | Major topic |
| Humans | |
| Animals | |
| Fecal Microbiota Transplantation | |
| Gastrointestinal Microbiome | |
| Immune Checkpoint Inhibitors |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P50 CA254865 | NCI NIH HHS | United States | P50CA254865 | PubMed and NIH | NIH RePORTER |
| R01 CA257265 | NCI NIH HHS | United States | R01CA257265 | PubMed and NIH | NIH RePORTER |
| R01 CA222203 | NCI NIH HHS | United States | R01CA222203 | PubMed and NIH | NIH RePORTER |
| ZIA BC010793 | Intramural NIH HHS | United States | ZIABC010793 | PubMed | NIH RePORTER |
| ZIA BC011152 | Intramural NIH HHS | United States | ZIABC011152 | PubMed | NIH RePORTER |
| U01 CA268806 | NCI NIH HHS | United States | U01CA268806 | PubMed and NIH | NIH RePORTER |
| ZIA BC011153 | Intramural NIH HHS | United States | ZIABC011153 | PubMed | NIH RePORTER |
References225
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27554295 | Mechanisms of inflammation-driven bacterial dysbiosis in the gut. | Mucosal Immunol | 2017 | https://conductscience.org/library/papers/27554295 | PubMed |
| 2 | 32101703 | Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation. | Cell Host Microbe | 2020 | https://conductscience.org/library/papers/32101703 | PubMed |
| 3 | 31182797 | IFN-I and IL-22 mediate protective effects of intestinal viral infection. | Nat Microbiol | 2019 | https://conductscience.org/library/papers/31182797 | PubMed |
| 4 | 29556534 | On the Road to Strain-Resolved Comparative Metagenomics. | mSystems | 2018 | https://conductscience.org/library/papers/29556534 | PubMed |
| 5 | 33976176 | Taxonomic signatures of cause-specific mortality risk in human gut microbiome. | Nat Commun | 2021 | https://conductscience.org/library/papers/33976176 | PubMed |
| 6 | 29798856 | Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. | Science | 2018 | https://conductscience.org/library/papers/29798856 | PubMed |
| 7 | 35702873 | A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer. | Cancer Med | 2023 | https://conductscience.org/library/papers/35702873 | PubMed |
| 8 | 36709367 | Relationship between gut microbiota and nutritional status in patients on peritoneal dialysis. | Sci Rep | 2023 | https://conductscience.org/library/papers/36709367 | PubMed |
| 9 | 33303685 | Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. | Science | 2021 | https://conductscience.org/library/papers/33303685 | PubMed |
| 10 | 35354477 | Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far. | J Biomed Sci | 2022 | https://conductscience.org/library/papers/35354477 | PubMed |
| 11 | 33239790 | The gut microbiota is associated with immune cell dynamics in humans. | Nature | 2020 | https://conductscience.org/library/papers/33239790 | PubMed |
| 12 | 31626055 | Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. | Med Sci Sports Exerc | 2019 | https://conductscience.org/library/papers/31626055 | PubMed |
| 13 | 33619379 | Gut microbiome pattern reflects healthy ageing and predicts survival in humans. | Nat Metab | 2021 | https://conductscience.org/library/papers/33619379 | PubMed |
| 14 | 38475836 | Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity. | Eur J Med Res | 2024 | https://conductscience.org/library/papers/38475836 | PubMed |
| 15 | 28142322 | Microbes and Cancer. | Annu Rev Immunol | 2017 | https://conductscience.org/library/papers/28142322 | PubMed |
| 16 | 35101349 | Immune-related adverse events in various organs caused by immune checkpoint inhibitors. | Allergol Int | 2022 | https://conductscience.org/library/papers/35101349 | PubMed |
| 17 | 32328469 | Current Sampling Methods for Gut Microbiota: A Call for More Precise Devices. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/32328469 | PubMed |
| 18 | 31398337 | Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. | Cell | 2019 | https://conductscience.org/library/papers/31398337 | PubMed |
| 19 | 30530851 | Microbiota and cancer immunotherapy: in search of microbial signals. | Gut | 2019 | https://conductscience.org/library/papers/30530851 | PubMed |
| 20 | 34239137 | Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. | Nat Med | 2021 | https://conductscience.org/library/papers/34239137 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42824830 | Mechanisms of microbiome-immune interactions in bladder cancer and targeted regulatory strategies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42824830 | PubMed |
| 42750046 | Decoding the cancer microbiome: multi-omics, AI, and translational opportunities. | Genome Biol | 2026 | https://conductscience.org/library/papers/42750046 | PubMed |
| 42614394 | Microbial metabolites and the gut-lung axis in non-small cell lung cancer immunotherapy: evidence boundaries and translational implications. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42614394 | PubMed |
| 42507333 | Microbiome-guided cancer immunotherapy: immune mechanisms, resistance pathways, and translational opportunities for precision oncology. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42507333 | PubMed |
| 42476727 | Safety and efficacy of fecal microbiota transplantation in solid cancers resistant to immune checkpoint inhibitors: results of the MITRIC trial. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42476727 | PubMed |
| 42382671 | The gut microbiome in colorectal cancer: molecular paradigms and translational frontiers. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42382671 | PubMed |
| 42345017 | Programming the tumor microenvironment through microbiome-driven mechanisms. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42345017 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41349548
GET https://conductscience.org/api/papers/v1/41349548/references?page=2